April 7 - 12, 2010 - Beaver Run Resort, Breckenridge, Colorado, USA
November 13, 2009
The large family of GPCRs includes many potential therapeutic targets, yet successful development of new drugs for GPCRs has been disappointing in spite of having access to all GPCR sequences in the genome, as well as physiologic insights from gene modification technology, larger more diverse compound libraries, and advances in high-throughput screening technologies. The goal of this meeting is to examine the challenges facing GPCR drug discovery, and to explore the application of structural biology, genomics and proteomics to GPCR target selection, and to lead identification and optimization.
Abstract deadlines :
Registration deadline :
Dans la même rubrique :